Direct treatment costs for patients with lung cancer from first recurrence to death in france.
Braud AC, Lévy-Piedbois C, Piedbois P, Piedbois Y, Livartovski A, Le Vu B, Trédaniel J, Reboul F, Brewer Y, Talbi S, Blanchon F, Paschen B, Durand-Zaleski I.
Braud AC, et al. Among authors: levy piedbois c.
Pharmacoeconomics. 2003;21(9):671-9. doi: 10.2165/00019053-200321090-00005.
Pharmacoeconomics. 2003.
PMID: 12807368